Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

3.4%

2 terminated out of 58 trials

Success Rate

87.5%

+0.9% vs benchmark

Late-Stage Pipeline

2%

1 trials in Phase 3/4

Results Transparency

7%

1 of 14 completed with results

Key Signals

1 with results88% success

Data Visualizations

Phase Distribution

56Total
Not Applicable (31)
Early P 1 (4)
P 1 (9)
P 2 (11)
P 3 (1)

Trial Status

Unknown15
Completed14
Recruiting14
Not Yet Recruiting7
Active Not Recruiting3
Terminated2

Trial Success Rate

87.5%

Benchmark: 86.6%

Based on 14 completed trials

Clinical Trials (58)

Showing 20 of 20 trials
NCT06282952Not ApplicableRecruitingPrimary

Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation

NCT07683936Early Phase 1Recruiting

Fecal Microbiota Transplantation for the Treatment of Refractory Hepatic Encephalopathy After TIPS Surgery

NCT07670299Not ApplicableNot Yet Recruiting

FMT for 90-Day Outcome of Clinical Use in ICU Sepsis

NCT05981430Not ApplicableNot Yet Recruiting

Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae

NCT07486492Early Phase 1Not Yet Recruiting

Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer

NCT07454408Phase 1Not Yet Recruiting

Evaluation of the Outcome of Fecal Microbiota Transplantation

NCT05917379Phase 1Completed

The Efficacy and Safty of FMT in Patients With CID

NCT07386795Not ApplicableNot Yet Recruiting

The Efficacy and Safety of Microbiota Transplantation Combined With Prebiotics for Treatment of Functional Constipation

NCT03325855RecruitingPrimary

Fecal Microbiota Transplant National Registry

NCT07154784Phase 2Enrolling By Invitation

Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis

NCT07149441Not ApplicableActive Not Recruiting

Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study

NCT05035342Phase 3Recruiting

Fecal Transplantation to Eradicate Colonizing Emergent Superbugs

NCT06920212Not ApplicableActive Not RecruitingPrimary

Clinical Safety and Efficacy of Fecal Microbiota Transplantation (FMT) in the Treatment of Alzheimer's Disease

NCT05273255Not ApplicableCompleted

Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy

NCT04970446Phase 1RecruitingPrimary

Microbial Restoration in Inflammatory Bowel Diseases

NCT06782880Not ApplicableRecruitingPrimary

Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation

NCT05821010Phase 2Recruiting

Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis

NCT03125564Not ApplicableCompleted

FMT for Patients With IBS With Fecal and Mucosal Microbiota Assessment

NCT05790356Not ApplicableRecruiting

Fecal Microbial Transplantation for Rheumatoid Arthritis Trial

NCT06297421Phase 2Not Yet Recruiting

Efficacy and Safety of FMT for the Treatment of IBS-D and Mental Health Comorbidity in Young Adults

Scroll to load more

Research Network

Activity Timeline